Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Neurology
•
Vascular Neurology
Would you avoid triptans in patients with CADASIL?
Related Questions
What considerations guide your decision to perform endovascular therapy in stroke involving acute M2 or M3 occlusions?
When do you consider treating intracerebral hemorrhage associated with cerebral amyloid angiopathy as an inflammatory CAA?
How do you medically manage acute basilar artery occlusion in patients with low NIHSS who are not candidates for EVT but at risk for deterioration?
Do you recommend CT perfusion in patients presenting with symptoms of acute stroke before 6 hours?
Is there a stroke volume threshold you use for giving or not giving DAPT for an acute ischemic stroke?
What is your approach to the management of asymptomatic intracranial atherosclerosis discovered during the workup of an acute stroke?
Do you screen children with sickle cell disease for silent cerebral infarcts?
What blood pressure targets do you enforce in the first 24-48 hours in a patient who develops an intracranial hemorrhage after mechanical thrombectomy?
How do you manage patients with a prior intracerebral hemorrhage from probable cerebral amyloid angiopathy who develop new small vessel ischemic infarcts?
When do you consider starting short-term DAPT in patients who present more than 24 hours after the onset of a high-risk TIA or minor stroke syndrome?
